Aalborg University

aau.dk

Matched: Aalborg University Hospital · Aalborg University

Total trials

372

Active

76

Phase 3

4

Total enrollment

720,961

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 13 of 13 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Lithium1
Cariprazine1
Picoprep1
Plenvu1
[68Ga]Ga-FAPI-46 PET/CT1
Ultrasound-guided corticosteroid2
Vehicle2
Local and systemical treatment1
Iodine-based contrast agent1
Gadolinium-based contrast agent1
Delgocitinib cream1
lidocaine cream1
Lidocaine+Delgocitinib1

Next readouts

  • 2024-09-30
  • 2024-10-31
  • 2025-12-01
  • 2026-12-31
  • 2027-04-30
  • 2028-03-21
  • 2028-09-01

Top conditions

  • Itch21
  • Healthy18
  • Pain14
  • Low Back Pain11
  • Histamine8
  • Cowhage8
  • Heart Failure7
  • Chronic Pain7

Frequently asked questions about Aalborg University

How many clinical trials does Aalborg University have on ClinicalTrials.gov?
Aalborg University is listed as the lead sponsor on 372 clinical trials in ClinicalTrials.gov, 76 of which are currently active (recruiting, enrolling, or ongoing).
How many of Aalborg University's trials are in Phase 3?
4 of Aalborg University's trials are in Phase 3, spread across 13 active drug programs.
What therapeutic areas does Aalborg University focus on?
Aalborg University's most-studied conditions on ClinicalTrials.gov are Itch, Healthy, Pain, Low Back Pain, Histamine.
When are Aalborg University's next clinical trial readouts?
Aalborg University has 7 upcoming primary-completion readouts tracked here; the soonest is “Feasibility of a Home Exercise Program With the Addition of a Corticosteroid Injection in Patients With Lateral Hip Pain”, expected around 2024-09-30.